Bronchicum Elixir

Download as pdf or txt
Download as pdf or txt
You are on page 1of 2

S7

Bronchicum® Elixir S  

Composition 
100 g solution contains: 
Thyme fluid extract (1:2-3) 5.0 g 
(Phenolic compound calculated as thymol NLT 0.03%)  ""
Primula root fluid extract (1:2-2.5) 2.5 g 
(Primulic acid NLT 0.25%) 
Indications 
Dietary supplement in case of cough. 

Dosage 
Adults: 
1 teaspoonful 3 times daily or as directed by physician.  
Children (4 years and above): 
according to age, ½ to one teaspoonful, 2-3 times daily.
 
Administration 
Bronchicum Elixir should be taken in doses distributed over the day at regular intervals. The  
duration of administration depends on the therapeutic necessity and is not limited to time.
 
Precautions and warnings  
- Shake well before use. 
- Avoid use in pregnancy.  
- May affect individuals with urinary tract or gastrointestinal inflammation. 
- Used with caution in individuals with thyroid disorders. 
- Spacing between doses NLT 4 hours. 
- The duration of continuous treatment should not exceed 7 days. 
- Keep out of reach of children. 
- Bronchicum Elixir is not to be taken in known hypersensitivity to one of the ingredients.

Packing

Carton box contains brown glass bottle of 100ml solution and an inner leaflet.
 
Storage
 
Store at temperature not exceeding 30° C in a dry place.

Dietary supplements are not intended to diagnose, treat, cure or prevent any disease. 

Produced by SANOFI ٍEgypt s.a.e. 


Under license of A. Nattermann & Cie GmbH – Germany one of sanofi-aventis companies. 
This insert was last approved in September 2014


Brand name: Bronchicum Elixir


Artwork type: Leaflet
Version number (Revision): S7
Bar code: 1242
SAP identification no.: E043321
Country: Egypt
Date: 09.2014
Designer: M Zaki
Dimensions: 300 x 200 mm
Logo version: A1
Minimum point size of text: 8 Pt.
Colors:
Process black
16/09/2015 15:29 - VISTAlink folder 1491679 - Page 1/2
E043321 - Pamph Bronchicum Elixir 100ml S7 S@n

Plant: CAIRO- EGYPT


Packaging material code: E043321
Packaging material name: Pamph Bronchicum Elixir 100ml S7
S@n
Second packaging material code: 41162
VISTAlink folder number: 1491679
VISTAlink PDF version: 2

This document has been digitally signed by the following people within the VISTAlink system,
following the sanofi-aventis group guidelines.

Reason Signed by Date


Sarah Haggag (Egypt regulatory
Market regulatory validation 03/09/2015 16:34:27
affairs team)
Randa Aref (Cairo quality
Plant quality validation 06/09/2015 11:13:24
assurance team)
Sara Bebawy (Cairo packaging
Plant final technical validation 06/09/2015 11:22:59
team)
Eman Fadel (Egypt medical
Market medical affairs validation 15/09/2015 17:14:56
affairs team)
Mohamed Fawzy (Egypt
Market marketing validation 16/09/2015 14:40:14
marketing department team)
Sara Bebawy (Cairo packaging
Plant ready to print 16/09/2015 15:29:49
team)

16/09/2015 15:29 - VISTAlink folder 1491679 - Page 2/2

You might also like